Lonza delivers 5.6% CER sales growth and 30% CORE EBITDA margin
Good momentum in commercial CDMO business
Good momentum in commercial CDMO business
First of its kind screening for Glaucoma at grass root level over 10k screened already
Convergent action on AMR identified as an important area of intervention
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
The collaboration between CORONA and Ferring will cater to patients across India
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
The Theme of the event was 'Building One Health Together – Improving Health Equity'
This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
Subscribe To Our Newsletter & Stay Updated